-
2
-
-
0042058435
-
Introduction
-
Stahl PH, Wermuth CG, eds, Weinheim: Wiley-VCH, Inc
-
Wermuth CG, Stahl PH. Introduction. In: Stahl PH, Wermuth CG, eds. Handbook of Pharmaceutical Salts: Properties, Selection and Use. Weinheim: Wiley-VCH, Inc: 2002:1-7.
-
(2002)
Handbook of Pharmaceutical Salts: Properties, Selection and Use
, pp. 1-7
-
-
Wermuth, C.G.1
Stahl, P.H.2
-
3
-
-
0021876419
-
Predictive relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug
-
Anderson BD, Conradi RA. Predictive relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug. J. Pharm. Sci. 1985;74(8):815-820.
-
(1985)
J. Pharm. Sci
, vol.74
, Issue.8
, pp. 815-820
-
-
Anderson, B.D.1
Conradi, R.A.2
-
4
-
-
0028219710
-
An integrated approach to the selection of optimal salt form for a new drug candidate
-
Morris KR, Fakes MG, Thakur AB, Newman AW, Singh AK, Venit JJ, Spagnuolo CJ, Serajuddin ATM. An integrated approach to the selection of optimal salt form for a new drug candidate. Int. J. Pharm. 1994;105(3):209-217.
-
(1994)
Int. J. Pharm
, vol.105
, Issue.3
, pp. 209-217
-
-
Morris, K.R.1
Fakes, M.G.2
Thakur, A.B.3
Newman, A.W.4
Singh, A.K.5
Venit, J.J.6
Spagnuolo, C.J.7
Serajuddin, A.T.M.8
-
5
-
-
0034607382
-
Salt form selection and characterization of LY333531 mesylate monohydrate
-
Engel GL, Farid NA, Faul MM, Richardson LA, Winneroski LL. Salt form selection and characterization of LY333531 mesylate monohydrate. Int. J. Pharm. 2000;198(2):239-247.
-
(2000)
Int. J. Pharm
, vol.198
, Issue.2
, pp. 239-247
-
-
Engel, G.L.1
Farid, N.A.2
Faul, M.M.3
Richardson, L.A.4
Winneroski, L.L.5
-
7
-
-
0141523555
-
Drug excipient interaction study of enalapril maleate using thermal analysis and scanning electron microscopy
-
Cotton ML, Wu DW, Vadas EB. Drug excipient interaction study of enalapril maleate using thermal analysis and scanning electron microscopy. Int. J. Pharm. 1987:40(1-2):129-142.
-
(1987)
Int. J. Pharm
, vol.40
, Issue.1-2
, pp. 129-142
-
-
Cotton, M.L.1
Wu, D.W.2
Vadas, E.B.3
-
8
-
-
0034997998
-
Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations
-
Omari AMM, Abdelah MK, Badwan AA, Jaber AMY. Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations. J. Pharm. Biomed. Anal. 2001:25(5-6):893-902.
-
(2001)
J. Pharm. Biomed. Anal
, vol.25
, Issue.5-6
, pp. 893-902
-
-
Omari, A.M.M.1
Abdelah, M.K.2
Badwan, A.A.3
Jaber, A.M.Y.4
-
9
-
-
51949094659
-
-
Janos F, Bela S, Attila B, Mueller CG, Tamas F, Sandor L, Gabor T. Salts of Enalpril. 2001, WO0132689.
-
Janos F, Bela S, Attila B, Mueller CG, Tamas F, Sandor L, Gabor T. Salts of Enalpril. 2001, WO0132689.
-
-
-
-
10
-
-
51949109486
-
ACE inhibitors nitric salts.
-
U.S. Patent 6218417
-
Soldato PD. ACE inhibitors nitric salts. 2001. U.S. Patent 6218417.
-
(2001)
-
-
Soldato, P.D.1
-
11
-
-
0031806352
-
In situ salt screening - a useful technique for discovery support and preformulation studies
-
Tong WQ, Whitesell G. In situ salt screening - a useful technique for discovery support and preformulation studies. Pharm. Dev. Technol. 1998;3(2):215-223.
-
(1998)
Pharm. Dev. Technol
, vol.3
, Issue.2
, pp. 215-223
-
-
Tong, W.Q.1
Whitesell, G.2
-
12
-
-
84981573659
-
A simple method of determining the aqueous solubility of organic substances
-
Fürer R, Geiger M. A simple method of determining the aqueous solubility of organic substances. J. Pharm. Sci. 1976;8(4):337-344.
-
(1976)
J. Pharm. Sci
, vol.8
, Issue.4
, pp. 337-344
-
-
Fürer, R.1
Geiger, M.2
-
13
-
-
0000496232
-
Classifying flow properties of solids
-
Carr RL. Classifying flow properties of solids. Chem. Eng. 1965;72:69-72.
-
(1965)
Chem. Eng
, vol.72
, pp. 69-72
-
-
Carr, R.L.1
-
14
-
-
0000496231
-
Evaluation of flow properties of solids
-
Carr RL. Evaluation of flow properties of solids. Chem. Eng. 1965;72:163-168.
-
(1965)
Chem. Eng
, vol.72
, pp. 163-168
-
-
Carr, R.L.1
-
15
-
-
51949116719
-
Process for preparing pharmacologically acceptable salt of
-
N-(1(S)-ethoxycarbonyl-3- phenylpropyl)-L-alanyl amino acids. 2002. U.S. Patent 6335453
-
Ueda Y, Kinoshita K, Moroshima T, Yanagida Y, Fuse Y. Process for preparing pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3- phenylpropyl)-L-alanyl amino acids. 2002. U.S. Patent 6335453.
-
-
-
Ueda, Y.1
Kinoshita, K.2
Moroshima, T.3
Yanagida, Y.4
Fuse, Y.5
-
16
-
-
1842689072
-
Pharmaceutical evaluation of early development candidates "the 100 mg-approach
-
Balbach S, Korn C. Pharmaceutical evaluation of early development candidates "the 100 mg-approach". Int. J. Pharm. 2004;275(1-2):1-12.
-
(2004)
Int. J. Pharm
, vol.275
, Issue.1-2
, pp. 1-12
-
-
Balbach, S.1
Korn, C.2
-
17
-
-
51949090874
-
-
ICH Harmonised Tripartite Guideline: Note for guidance on impurities - residual solvents Q3C (R3); 2005. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use http://www.ich.org/LOB/media/MEDIA423.pdf (accessed Nov. 2007).
-
ICH Harmonised Tripartite Guideline: Note for guidance on impurities - residual solvents Q3C (R3); 2005. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use http://www.ich.org/LOB/media/MEDIA423.pdf (accessed Nov. 2007).
-
-
-
-
18
-
-
84907035417
-
Equilibrium moisture content of pharmaceutical excipients
-
Callahan JC, Cleary JW, Elefant M, Kaplan G, Kensler T, and Nash RA. Equilibrium moisture content of pharmaceutical excipients. Drug Dev. Ind. Pharm. 1982;8(3):355-369.
-
(1982)
Drug Dev. Ind. Pharm
, vol.8
, Issue.3
, pp. 355-369
-
-
Callahan, J.C.1
Cleary, J.W.2
Elefant, M.3
Kaplan, G.4
Kensler, T.5
Nash, R.A.6
-
20
-
-
36549048649
-
Applications of X-ray powder diffraction in the pharmaceutical industry
-
Stephenson GA. Applications of X-ray powder diffraction in the pharmaceutical industry. Rigaku J. 2005;22(1):2-15.
-
(2005)
Rigaku J
, vol.22
, Issue.1
, pp. 2-15
-
-
Stephenson, G.A.1
-
21
-
-
23444448160
-
Characterization of polymorphic solid-state changes using variable temperature x-ray powder diffraction
-
Karjalainen M, Airaksinen S, Rantanen J, Aaltonen J, Yliruusi J. Characterization of polymorphic solid-state changes using variable temperature x-ray powder diffraction. J. Pharm. Biomed. Anal. 2005;39(1-2):27-32.
-
(2005)
J. Pharm. Biomed. Anal
, vol.39
, Issue.1-2
, pp. 27-32
-
-
Karjalainen, M.1
Airaksinen, S.2
Rantanen, J.3
Aaltonen, J.4
Yliruusi, J.5
-
22
-
-
19544391084
-
Variable-temperature x-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole
-
de Villiers MM, Terblanche RJ, Liebenberg W, Swanepoel E, Dekker TG, Song M. Variable-temperature x-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole. J. Pharm. Biomed. Anal. 2005;38(3):435-441.
-
(2005)
J. Pharm. Biomed. Anal
, vol.38
, Issue.3
, pp. 435-441
-
-
de Villiers, M.M.1
Terblanche, R.J.2
Liebenberg, W.3
Swanepoel, E.4
Dekker, T.G.5
Song, M.6
-
23
-
-
0015454626
-
Elastic recovery and surface area changes in compacted powder systems
-
Armstrong NA, Haines-Nutt RF. Elastic recovery and surface area changes in compacted powder systems. J. Pharm. Pharmacol. 1972;24:135P-136.
-
(1972)
J. Pharm. Pharmacol
, vol.24
-
-
Armstrong, N.A.1
Haines-Nutt, R.F.2
-
24
-
-
0037452412
-
Determining the compression behavior of pharmaceutical powders from the force-distance compression profile
-
Antikainen O, Yliruusi J. Determining the compression behavior of pharmaceutical powders from the force-distance compression profile. Int. J. Pharm. 2003;252(1-2): 253-261.
-
(2003)
Int. J. Pharm
, vol.252
, Issue.1-2
, pp. 253-261
-
-
Antikainen, O.1
Yliruusi, J.2
-
25
-
-
0035013530
-
Influence of elastic deformation of particles on Heckel analysis
-
Sun C, Grant DJW. Influence of elastic deformation of particles on Heckel analysis. Pharm. Dev. Technol. 2001:6(2):193-200.
-
(2001)
Pharm. Dev. Technol
, vol.6
, Issue.2
, pp. 193-200
-
-
Sun, C.1
Grant, D.J.W.2
|